Bod Australia’s shares rise as it prepares to launch cannabis-based cosmetics
Friday, 10 November 2017 Bod Australia Ltd (ASX:BDA) has commenced exploratory formulation work on a new range of cannabis-based cosmetic products via its partnership with Swiss herbal extracts company Linnea SA. Bod’s share prices has increased 70% in the past one week and is trading at $0.17 intra-day. Pursuant to the agreement, Linnea will also assist Bod in developing cannabis-based topical treatments for inflammation and sensitive skin, including serums, foam-based creams and balms. A key value-driver for the new cosmetic range will be the use of Linnea’s unique NioSkin™ ingredient as an active ingredient and transporter of the cannabis. NioSkin provides superior therapeutic outcomes than standard cannabis cosmetics by efficiently enhancing skin penetration of the cannabis-based extracts. Bod is currently conducting research and development for its cannabis-based skincare products and is planning to commercialise and distribute the products to consumers by 2018. The products will be developed and manufactured at facilities in Italy, and exported to numerous major markets beyond Australia, including Asia and the Americas. Discussions are underway with third-parties for white labelling and wholesale distribution. The global skincare market is expected to reach $233.7 billion by 2022.
Canadian cannabis activists say their work is far from over even as the legalization of marijuana looms. Jodie Emery, known as the “princess of pot,” says shifting focus to criminal justice is part of how cannabis activism will change.
Canadian marijuana producer and distributor WeedMD Inc (CVE:WMD) has joined the world-renowned Cannabis Database Project led by the Technion-Israel Institute of... Proactive Investors - BusinessAlso reported by •GlobeNewswire